Casalpusterlengo, Italy

Alessandro Donadelli


Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2003-2006

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Alessandro Donadelli

Introduction

Alessandro Donadelli is a notable inventor based in Casalpusterlengo, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of cephalosporins. With a total of two patents to his name, Donadelli's work has had a considerable impact on the industry.

Latest Patents

Donadelli's latest patents include a coupling process and intermediates useful for preparing cephalosporins. This process involves the preparation of 3-cyclic-ether-substituted cephalosporins, where specific groups and compounds are utilized in the presence of a solvent and a base. Another significant patent is for a process that obtains compounds usable in the production of Cefotetan. This safe and economical method involves refluxing specific salts in an aqueous solution to produce desired salts, which can then be used for producing semi-synthetic cephalosporins.

Career Highlights

Throughout his career, Donadelli has worked with prominent companies such as ACS Dobfar S.p.A. and Pfizer Corporation. His experience in these organizations has allowed him to refine his skills and contribute to important pharmaceutical advancements.

Collaborations

Donadelli has collaborated with notable colleagues, including Maurizio Zenoni and Marco Silvagni. These partnerships have likely enhanced his research and development efforts in the pharmaceutical field.

Conclusion

Alessandro Donadelli's innovative work in the pharmaceutical industry, particularly in the development of cephalosporins, showcases his expertise and dedication to advancing medical science. His patents reflect a commitment to creating effective and safe pharmaceutical processes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…